Carpenter Technology Corporation is a Philadelphia-based producer of premium specialty alloys and high-performance metal products. The company serves aerospace and defense, medical, energy, transportation, and industrial markets, supplying materials that must withstand extreme heat, pressure, and corrosion. Its two reportable segments are Specialty Alloys Operations (SAO), its core premium alloy and stainless steel manufacturing business, and Performance Engineered Products (PEP), which includes the Dynamet titanium business, additive manufacturing, and distribution operations.
Investors follow CRS closely because of its deep exposure to the commercial aerospace ramp, jet-engine nickel superalloys, and defense programs. Competitive strengths include specialized metallurgy expertise, long-term supply agreements with major aerospace customers, and pricing power driven by a tight supply-demand balance for premium alloys. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Over the past 30 days, CRS fell roughly 26%, from a closing price of $395.71 on October 6 to $292.10 as of the November 4 close. The most severe single-day move occurred on October 22, when the stock dropped about 20.6%, or $75.93, following its quarterly earnings release.
The decline extends a much deeper multi-month slide. Measured over the trailing three months, CRS is down approximately 49%, from about $571 in early August to its current level. The stock also trades more than 50% below its 52-week high near $626, reached in mid-2026.
The primary catalyst was the first-quarter fiscal 2027 earnings report on October 22, 2026. Net sales rose 8.8% year over year to $798.2 million but came in below consensus estimates near $830 million. Diluted earnings per share of $3.25 beat expectations of roughly $3.04, and operating income of $196.4 million set a first-quarter record, up 28% year over year. However, total sales excluding surcharge declined 7% sequentially, which management attributed to planned preventive-maintenance outages, and SAO operating income of $216.3 million fell 6% sequentially, below the company's prior guidance.
Investors also reacted to softer near-term guidance. Management projected second-quarter operating income of $192 million to $197 million, below some expectations. Negative free cash flow of $24.8 million, reflecting elevated capital expenditures on a brownfield expansion and an inventory build, added to concerns. On October 26, KeyBanc downgraded the stock to Sector Weight from Overweight, citing the softer second-quarter outlook, production disruptions, defense funding uncertainty, and weak sentiment. Several law firms subsequently announced securities-fraud investigations into the company's disclosures. Offsetting these pressures, management reaffirmed full-year operating income guidance of $850 million to $880 million, highlighted record aerospace bookings, and authorized a new $1 billion buyback.
The quarterly decline reflects a broader reset of a richly valued stock rather than a collapse in fundamentals. CRS rallied to a 52-week high near $626 in mid-2026 as investors priced in strong aerospace demand and expanding margins. Over the following months, the stock gave back those gains as concerns mounted about a premium valuation, sequential revenue growth, and near-term cash flow.
Demand drivers remained intact: commercial aerospace bookings continued to accelerate, the FAA approved the Boeing 737 MAX 10, and management maintained its fiscal 2029 operating income target of $1.2 billion to $1.3 billion. But softer defense funding clarity, planned maintenance downtime, lower PEP sales driven by weaker titanium demand in medical markets, and heavy capital spending weighed on sentiment. The result was a pronounced de-rating of a name that had traded at a substantial premium to its historical multiples.
Investors should monitor Carpenter Technology's second-quarter fiscal 2027 results, scheduled for early February 2027, against the company's operating income outlook of $192 million to $197 million. Key themes include the pace of aerospace order intake and whether bookings translate into accelerating sales, the trajectory of SAO margins from their record 37.7% level, and the company's progress toward its full-year free cash flow target of $400 million to $430 million. Defense budget clarity following U.S. elections, nickel superalloy supply-demand dynamics, and the timing of the brownfield capacity expansion are additional factors to watch. As always, actual results will depend on execution, end-market demand, and broader macroeconomic conditions. From what I see, these elements will shape near-term moves.
In my research process, I often review Tickeron's Trending AI Robots to compare automated trading approaches across different market conditions and timeframes. This resource highlights top-performing bots that use AI-driven strategies on thousands of tickers, allowing investors to evaluate systematic options alongside traditional analysis without relying on any single signal.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CRS's RSI Indicator exited the oversold zone, 12 of 17 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
Following a +4.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRS advanced for three days, in 281 of 347 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
CRS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Moving Average Convergence Divergence Histogram (MACD) for CRS turned negative on October 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 38 similar instances when the indicator turned negative. In 28 of the 38 cases the stock turned lower in the days that followed. This puts the odds of success at 74%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 75%.
The Aroon Indicator for CRS entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron SMR rating for this company is 37 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 53 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 75, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 78 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 79 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: CRS's P/B Ratio (6.498) is slightly higher than the industry average of (3.106). P/E Ratio (27.583) is within average values for comparable stocks, (9.253). Projected Growth (PEG Ratio) (1.380) is also within normal values, averaging (0.744). Dividend Yield (0.003) settles around the average of (0.029) among similar stocks. P/S Ratio (6.645) is also within normal values, averaging (6248.204).
The Tickeron Price Growth Rating for this company is 82 (best 1 - 100 worst), indicating slightly worse than average price growth. CRS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of specialty metals
Industry MetalFabrication